{
    "nct_id": "NCT03044197",
    "official_title": "Assessing the Detection of Clinically Significant Prostate Cancer Using Magnetic Resonance Imaging-Guided Transperineal Targeted Biopsy Compared to Standard Transrectal Biopsy Outcomes Study: The ASTROS Trial",
    "inclusion_criteria": "1. Males aged 18-75 years old\n2. PSA >1 ng/ml but <15 ng/ml\n3. Negative DRE\n4. Signed informed consent\nHealthy volunteers allowed\nMust be MALE\nMust have minimum age of 18 Years\nMust have maximum age of 75 Years",
    "exclusion_criteria": "1. Previous prostate biopsy or prostate surgery\n2. Previous prostate mpMRI\n3. Contraindication to mpMRI: patients with pacemakers, defibrillators or other implanted electronic devices\n4. Patients in the Texas Department of Criminal Justice (prisoners)\n5. Patients with acute urinary symptoms including urinary retention and urinary tract infection",
    "miscellaneous_criteria": ""
}